Tag: BridgeBio Pharma

Analyst Lowers BridgeBio Price Target After Debt Issuance

George Farmer told investors that BMO Capital Markets is lowering its price target for BridgeBio Pharma to US$46, down from...

Biotech Market Update: Q2 2019 in Review

With Q2 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...